journal article·2018-11-12Open access

In loco retention effect of magnetic core mesoporous silica nanoparticles doped with trastuzumab as intralesional nanodrug for breast cancer

Filipe Leal Portilho, Suyene Rocha Pinto, Aline Oliveira da Silva de Barros, Edward Helal-Neto, Sofia Nascimento dos Santos, Emerson Soares Bernardes, Derya Ilem-Ozdemir, Makbule Asikoglu, Luciana Magalhães Rebelo Alencar, Clenilton Costa dos Santos, Eduardo Ricci-Junior, Félix Sancenón, Ramón Martínez-Máñez, Ralph Santos-Oliveira

Abstract

/g with a pore diameter of 3.15 nm. The magnetic core mesoporous silica was efficiently labelled with 99mTc (97.5% ±0.8) and doped >98%. The cytotoxicity assay, demonstrated they are safe to use. The data were corroborated with the IC50 result of: 829.6 µg ± 43.2. The biodistribution showed an uptake by the tumour of 7.5% (systemic via) and 97.37% (intralesional) with less than 3% of these nanoparticles absorbed by healthy tissues. In a period 6-h post-injection, no barrier delimited by the tumour was crossed, corroborating the use as intralesional nanodrug.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Cancer Cells and Metastasis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Brazilian Nuclear Energy Commission, Nuclear Engineering Institute

Laboratory of Nanoradiopharmaceuticals, Zona Oeste State University

Centro de Radiofarmacia, Instituto de Pesquisas Energéticas e Nucleares

Department of Radiopharmacy, Faculty of Pharmacy, Ege University

Faculty of Pharmacy, Federal University of Rio de Janeiro

Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València

Departamento de Química, Universidad Politécnica de Valencia

CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)

Funding

National Scientific and Technological Research Council · Rio de Janeiro State Research Foundation · Ministerio de Economía y Competitividad · Generalitat Valenciana

References (29)

Show source-provided references
1. 10.3322/caac.2007310.3322/caac.20073 ↗
2. 10.1016/j.ygyno.2008.10.01810.1016/j.ygyno.2008.10.018 ↗
3. 10.1016/j.biomaterials.2017.02.02010.1016/j.biomaterials.2017.02.020 ↗
4. 10.1016/j.micromeso.2016.10.04110.1016/j.micromeso.2016.10.041 ↗
5. 10.1080/21691401.2018.146060310.1080/21691401.2018.1460603 ↗
6. 10.1016/j.jconrel.2018.05.00310.1016/j.jconrel.2018.05.003 ↗
7. 10.1016/j.jconrel.2018.05.00310.1016/j.jconrel.2018.05.003 ↗
8. 10.3109/21691401.2016.116371710.3109/21691401.2016.1163717 ↗
9. 10.1007/s10967-015-4210-610.1007/s10967-015-4210-6 ↗
10. 10.1007/s10967-016-4805-610.1007/s10967-016-4805-6 ↗
11. 10.1016/j.jpba.2018.02.01710.1016/j.jpba.2018.02.017 ↗
12. 10.1080/21691401.2017.130784810.1080/21691401.2017.1307848 ↗
13. 10.2147/IJN.S11848210.2147/IJN.S118482 ↗
14. 10.1016/j.nucmedbio.2014.05.14110.1016/j.nucmedbio.2014.05.141 ↗
15. 10.1016/j.ejpb.2013.10.01110.1016/j.ejpb.2013.10.011 ↗
16. 10.1016/0009-2797(84)90058-910.1016/0009-2797(84)90058-9 ↗
17. Last JA, Reiser KM. Effects of silica on lung collagen. Ciba Found Symp. 1986;121:180–193.
18. Reverberi R, Reverberi L. Factors affecting the antigen-antibody reaction. Blood Transfus. 2007;5:227–240.
19. 10.1016/j.nantod.2015.06.00610.1016/j.nantod.2015.06.006 ↗
20. 10.1016/j.biomaterials.2016.05.03010.1016/j.biomaterials.2016.05.030 ↗
21. 10.1016/j.biomaterials.2017.10.04710.1016/j.biomaterials.2017.10.047 ↗
22. 10.1016/j.actbio.2016.11.00710.1016/j.actbio.2016.11.007 ↗
23. 10.1039/b905158a10.1039/b905158a ↗
24. 10.1186/s12951-015-0068-610.1186/s12951-015-0068-6 ↗
25. 10.1038/s41598-017-02531-410.1038/s41598-017-02531-4 ↗
26. 10.1021/nn900918w10.1021/nn900918w ↗
27. Coulson A, Levy A, Gossel-Williams M. Monoclonal antibodies in cancer therapy: mechanism, successes and limitations. West Indian Med J. 2014;63:650–654.
28. 10.1293/tox.2015-003110.1293/tox.2015-0031 ↗
29. 10.2174/187447100666613111921201510.2174/1874471006666131119212015 ↗